The kynurenine pathway and the brain: Challenges, controversies and promises
R Schwarcz, TW Stone - Neuropharmacology, 2017 - Elsevier
Research on the neurobiology of the kynurenine pathway has suffered years of relative
obscurity because tryptophan degradation, and its involvement in both physiology and major …
obscurity because tryptophan degradation, and its involvement in both physiology and major …
Kynurenines in the mammalian brain: when physiology meets pathology
R Schwarcz, JP Bruno, PJ Muchowski… - Nature Reviews …, 2012 - nature.com
The essential amino acid tryptophan is not only a precursor of serotonin but is also
degraded to several other neuroactive compounds, including kynurenic acid, 3 …
degraded to several other neuroactive compounds, including kynurenic acid, 3 …
Kynurenines: from the perspective of major psychiatric disorders
AM Myint - The FEBS journal, 2012 - Wiley Online Library
Psychiatric disorders are documented to be associated with a mild pro‐inflammatory state.
Pro‐inflammatory mediators could activate the tryptophan breakdown and kynurenine …
Pro‐inflammatory mediators could activate the tryptophan breakdown and kynurenine …
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance
TW Stone - Progress in neurobiology, 2001 - Elsevier
In just under 20 years the kynurenine family of compounds has developed from a group of
obscure metabolites of the essential amino acid tryptophan into a source of intensive …
obscure metabolites of the essential amino acid tryptophan into a source of intensive …
Kynurenines in the CNS: recent advances and new questions
Various pathologies of the central nervous system (CNS) are accompanied by alterations in
tryptophan metabolism. The main metabolic route of tryptophan degradation is the …
tryptophan metabolism. The main metabolic route of tryptophan degradation is the …
Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders
The kynurenine pathway constitutes the main route of tryptophan degradation and
generates the production of several neuroactive compounds; quinolinic acid is an excitotoxic …
generates the production of several neuroactive compounds; quinolinic acid is an excitotoxic …
The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
TW Stone, LG Darlington - British journal of pharmacology, 2013 - Wiley Online Library
Understanding the neurochemical basis for cognitive function is one of the major goals of
neuroscience, with a potential impact on the diagnosis, prevention and treatment of a range …
neuroscience, with a potential impact on the diagnosis, prevention and treatment of a range …
Endogenous kynurenines as targets for drug discovery and development
TW Stone, LG Darlington - Nature reviews Drug discovery, 2002 - nature.com
The kynurenine pathway is the main pathway for tryptophan metabolism. It generates
compounds that can modulate activity at glutamate receptors and possibly nicotinic …
compounds that can modulate activity at glutamate receptors and possibly nicotinic …
Kynurenine pathway metabolites in humans: disease and healthy states
Y Chen, GJ Guillemin - International journal of tryptophan …, 2009 - journals.sagepub.com
Tryptophan is an essential amino acid that can be metabolised through different pathways, a
major route being the kynurenine pathway. The first enzyme of the pathway, indoleamine-2 …
major route being the kynurenine pathway. The first enzyme of the pathway, indoleamine-2 …
Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders
K O'Farrell, A Harkin - Neuropharmacology, 2017 - Elsevier
The kynurenine pathway (KP), which is activated in times of stress and infection has been
implicated in the pathophysiology of neurodegenerative and psychiatric disorders. Activation …
implicated in the pathophysiology of neurodegenerative and psychiatric disorders. Activation …